INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![trial-CRO-meeting-GettyImages-1206260023]( "Creating A New World In Clinical Trial Feasibility Utilizing Advanced Analytics")
Creating A New World In Clinical Trial Feasibility Utilizing Advanced AnalyticsCiteline utilizes several data resources to enhance feasibility strategies and help clients drive patient engagement and recruitment.
-
![GettyImages-879831370_cells lab]( "Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs")
Podcast―Nonclinical Considerations When Developing Ophthalmic DrugsGlobally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
![korio_rtsm__site_user_experience]( "Korio RTSM Platform: Site User Experience")
Korio RTSM Platform: Site User ExperienceWith minimal navigation, users of this platform can view a participant list, demographics, and status indicators — taking key actions like screening or randomizing without leaving the main grid.
-
![GettyImages-1300085414-team-collaboration]( "Enhancing Clinical Trial Flexibility")
Enhancing Clinical Trial FlexibilityOnce seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
Two Views Of Risk When Choosing An IRT/RTSM Software Partner5/5/2026
In this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors.
-
The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up9/3/2025
Transactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.
-
Successful Regulatory Submission Via The Trifecta Of Awesomeness1/17/2025
Three essential elements contribute to a repeatable, adaptable regulatory submission process: strategic planning, team engagement, and properly leveraging team experience.
-
Expedite Drug Development With An Integrated CDMO-CRO Model2/6/2026
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
The Rise Of Targeted Modalities In Pharmaceutical Development8/11/2025
Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1295039463-dna-research-computer-lab]( "Elevate Your Research With Comprehensive Tools And Expertise")
Streamline study activation and increase efficiencies with the partner trusted by tens of thousands of sites, institutions, academic medical centers, cancer centers, and health systems worldwide.
-
![GettyImages-1256323645 lab, biotech]( "Accelerate Your Clinical Trials In Australia")
Accelerate your biotech trials in Australia—cut costs by up to 60%, enroll patients in as little as 4–6 weeks, and generate FDA- and EMA-accepted data with no IND required.
-
![Safety & Pharmacovigilance Solutions]( "Pharmacovigilance")
The quality of your drug safety team is of the highest importance. That’s why you need an experienced and committed partner who commands the regulatory landscape with confidence. Our global and scalable safety solutions are designed to be efficient, affordable, and fully compliant, giving you flexibility and peace of mind in a complex clinical environment.
-
![clinical-drug-development-GettyImages-1354172647]( "Drug Safety And Pharmacovigilance Services")
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
![GettyImages-1165109678-handshake-partner-business-agreement]( "Proven Expertise With Global Solutions For U.S. Biotechs")
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.
